Variable | MDM2SNP309 genotype (Control/Case) | Adjusted OR (95% CI) †| Pvalue | ||
---|---|---|---|---|---|
 | TT + TG | GG | TT + TG | GG |  |
Location | Â | Â | Â | Â | Â |
  Cardia | 495/141 | 79/40 | 1.00 | 1.84 (1.20-2.83) | < 0.01 |
  Non-cardia | 495/292 | 79/101 | 1.00 | 2.18 (1.57-3.04) | < 0.01 |
Vascular invasion | Â | Â | Â | Â | Â |
  Absent | 495/265 | 79/98 | 1.00 | 2.33 (1.67-3.26) | < 0.01 |
  Present | 495/168 | 79/43 | 1.00 | 1.60 (1.06-2.42) | 0.03 |
Lymph node metastasis | Â | Â | 1.00 | Â | Â |
  Absent | 495/138 | 79/35 | 1.00 | 1.59 (1.02-2.47) | 0.04 |
  Present | 495/295 | 79/106 | 1.00 | 2.25 (1.63-3.12) | < 0.01 |
Liver metastasis | Â | Â | 1.00 | Â | Â |
  Absent | 495/391 | 79/121 | 1.00 | 1.94 (1.42-2.65) | < 0.01 |
  Present | 495/42 | 79/20 | 1.00 | 3.34 (1.84-6.08) | < 0.01 |
Peritoneal dissemination | Â | Â | Â | Â | Â |
  Absent | 495/380 | 79/123 | 1.00 | 2.04 (1.49-2.79) | < 0.01 |
  Present | 495/53 | 79/18 | 1.00 | 2.13 (1.18-3.84) | 0.01 |
TNM stage | Â | Â | Â | Â | Â |
  IA | 495/75 | 79/21 | 1.00 | 1.75 (1.01-3.00) | 0.04 |
  IB | 495/60 | 79/19 | 1.00 | 2.01 (1.13-3.57) | 0.01 |
  II | 495/83 | 79/24 | 1.00 | 1.78 (1.06-2.98) | 0.03 |
  III | 495/127 | 79/46 | 1.00 | 2.30 (1.52-3.49) | < 0.01 |
  IV | 495/88 | 79/31 | 1.00 | 2.29 (1.42-3.69) | < 0.01 |